MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-25-0000527
Synfine Drugs Private Limited
Synfine Drugs Private Limited - pharma in Sangareddy, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹7.97 Cr
▲ 12% YoY
Net profit · FY 2023
₹1.1 Cr
Net margin 13.8%
EBITDA · FY 2023
₹3.15 Cr
EBITDA margin 39.6%
Authorised capital
₹11 Cr
Registered with MCA
Paid-up capital
₹4.87 Cr
Issued & subscribed
Open charges
₹11 Cr
Satisfied ₹9.51 Cr
Company age
9 yrs
Est. 2017
Employees · EPFO
21
Provident fund records
About Synfine Drugs Private Limited
Data last updated:
Synfine Drugs Private Limited is a private limited company based in Sangareddy, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2017PTC116006. Its GSTIN is 36AAYCS3637E1ZW (Telangana).
The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹4.87 Cr. It is led by directors Saida Reddy Battu (Managing Director) and Chandra Kala Battu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Survey No 637 Temple Road Bonthapally (Village) Gummadidala (Mandal), Sangareddy, Telangana, India – 502313.
As per the financials filed for FY 2023, the company reported a revenue of ₹7.97 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹1.1 Cr (net margin 13.8%) and EBITDA of ₹3.15 Cr (EBITDA margin 39.6%).
The company has about 21 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Synfine Drugs. As per MCA filings, the company has open charges of ₹11 Cr and satisfied charges of ₹9.51 Cr on record.
Synfine Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-25-0000527). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24304TG2017PTC116006
Registration Number 116006
Incorporation Date 20 March 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-25-0000527
Recognitions & Rankings of Synfine Drugs
Contact details
Synfine Drugs Private Limited's registered office is in Sangareddy, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSurvey No 637 Temple Road Bonthapally (Village) Gummadidala (Mandal), Sangareddy, Telangana, India – 502313
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Synfine Drugs Private Limited, buy the company report.
Comprehensive company report
Synfine Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Synfine Drugs operates one associated brand: Synfine Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports pharmaceutical intermediates and active ingredients globally. | synfinedrugs.com |
Financials of Synfine Drugs Private Limited
FY 2025 filings availableSynfine Drugs Private Limited reported revenue of ₹7.97 Cr (up 12% YoY) for FY 2023.
Revenue · FY 2023
₹7.97 Cr ▲ 12%
Net profit · FY 2023
₹1.1 Cr margin 13.8%
EBITDA · FY 2023
₹3.15 Cr margin 39.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
EBITDA CAGR growth
1 year
▲ 57%
Revenue rose 12% in the latest year. EBITDA rose 57% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹7.97 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.15 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 39.6% | ||||
| Net Profit Margin | 13.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synfine Drugs Private Limited, buy the company report.
Board of directors of Synfine Drugs Private Limited
Synfine Drugs has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saida Reddy Battu | Managing Director | 20 Mar 2017 | 9 Years 7 Months | Current |
| Chandra Kala Battu | Director | 20 Mar 2017 | 9 Years 7 Months | Current |
Auditor
Synfine Drugs Private Limited is audited by N SAI KRISHNA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N SAI KRISHNA & CO | FY 2023 | 014965S |
Shareholding
The shareholding of Synfine Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Synfine Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹11 Cr
Satisfied charges
₹9.51 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Nov 2024 | 101021956 | Others | ₹2 Cr | Open | |
| 21 Nov 2024 | 101022083 | Others | ₹9 Cr | Open | |
| 04 Sep 2019 | 100290357 | State Bank of India | ₹9.51 Cr | Satisfied |
To see the full charge records of Synfine Drugs Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Synfine Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synfine Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Synfine Drugs Private Limited has a workforce of 21 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
Employee count
21
Active EPFO establishments
1
Employee growth
-4.55%
GST
Synfine Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAYCS3637E1ZW | Telangana | Active | 29 Dec 2017 |
To see the full GST registrations and return filing status of Synfine Drugs Private Limited, buy the company report.
Recent activity
Synfine Drugs Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Chandra Kala Battu was appointed as Director on 20 Mar 2017.
AGM
Synfine Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Synfine Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101021956 was registered on 21 Nov 2024.
Charges
A charge with Others amounted to Rs. 9.00 Cr with Charge ID 101022083 was registered on 21 Nov 2024.
Charges
A charge registered on 04 Sep 2019 via Charge ID 100290357 with State Bank Of India was fully satisfied on 18 Nov 2024.
Charges
A charge with State Bank Of India of Rs. 9.51 Cr registered on 04 Sep 2019 with Charge ID 100290357 was modified on 07 Jun 2023.
Charges
A charge with State Bank Of India amounted to Rs. 9.51 Cr with Charge ID 100290357 was registered on 04 Sep 2019.
Appointed
Chandra Kala Battu was appointed as Director.
Appointed
Saida Reddy Battu was appointed as Managing Director.
Incorporation
20 Mar 2017
Synfine Drugs Private Limited was registered on 20 Mar 2017 with Roc Hyderabad & aged 9 years 7 months as per MCA records.
Frequently asked questions
Synfine Drugs is an active private limited company based in Sangareddy, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 March 2017 (9+ years old) and is registered under CIN U24304TG2017PTC116006.
Synfine Drugs has 2 current directors:
- Saida Reddy Battu - Managing Director
- Chandra Kala Battu - Director
The latest financial statements of Synfine Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Synfine Drugs is 36AAYCS3637E1ZW, registered in Telangana.
The CIN (Corporate Identification Number) of Synfine Drugs is U24304TG2017PTC116006. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synfine Drugs was incorporated on 20 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Chandra Kala Battu was appointed as Director on 20 Mar 2017. Saida Reddy Battu was appointed as Managing Director on 20 Mar 2017.
Yes, Synfine Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-TS-25-0000527).
The registered office of Synfine Drugs is at Survey No 637 Temple Road Bonthapally Village Gummadidala Mandal, Sangareddy, Telangana, India – 502313.
Synfine Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages